1wut: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
New page: left|200px<br /><applet load="1wut" size="450" color="white" frame="true" align="right" spinBox="true" caption="1wut, resolution 2.26Å" /> '''Acyl Ureas as Human ...
 
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:1wut.gif|left|200px]]<br /><applet load="1wut" size="450" color="white" frame="true" align="right" spinBox="true"  
[[Image:1wut.gif|left|200px]]<br /><applet load="1wut" size="350" color="white" frame="true" align="right" spinBox="true"  
caption="1wut, resolution 2.26&Aring;" />
caption="1wut, resolution 2.26&Aring;" />
'''Acyl Ureas as Human Liver Glycogen Phosphorylase Inhibitors for the Treatment of Type 2 Diabetes'''<br />
'''Acyl Ureas as Human Liver Glycogen Phosphorylase Inhibitors for the Treatment of Type 2 Diabetes'''<br />


==Overview==
==Overview==
Acyl ureas were discovered as a novel class of inhibitors for glycogen, phosphorylase, a molecular target to control hyperglycemia in type 2, diabetics. This series is exemplified by 6-{2,6-Dichloro-, 4-[3-(2-chloro-benzoyl)-ureido]-phenoxy}-hexanoic acid, which inhibits, human liver glycogen phosphorylase a with an IC(50) of 2.0 microM. Here we, analyze four crystal structures of acyl urea derivatives in complex with, rabbit muscle glycogen phosphorylase b to elucidate the mechanism of, inhibition of these inhibitors. The structures were determined and refined, to 2.26 Angstroms resolution and demonstrate that the inhibitors bind at, the allosteric activator site, where the physiological activator AMP, binds. Acyl ureas induce conformational changes in the vicinity of the, allosteric site. Our findings suggest that acyl ureas inhibit glycogen, phosphorylase by direct inhibition of AMP binding and by indirect, inhibition of substrate binding through stabilization of the T' state.
Acyl ureas were discovered as a novel class of inhibitors for glycogen phosphorylase, a molecular target to control hyperglycemia in type 2 diabetics. This series is exemplified by 6-{2,6-Dichloro- 4-[3-(2-chloro-benzoyl)-ureido]-phenoxy}-hexanoic acid, which inhibits human liver glycogen phosphorylase a with an IC(50) of 2.0 microM. Here we analyze four crystal structures of acyl urea derivatives in complex with rabbit muscle glycogen phosphorylase b to elucidate the mechanism of inhibition of these inhibitors. The structures were determined and refined to 2.26 Angstroms resolution and demonstrate that the inhibitors bind at the allosteric activator site, where the physiological activator AMP binds. Acyl ureas induce conformational changes in the vicinity of the allosteric site. Our findings suggest that acyl ureas inhibit glycogen phosphorylase by direct inhibition of AMP binding and by indirect inhibition of substrate binding through stabilization of the T' state.


==About this Structure==
==About this Structure==
1WUT is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Oryctolagus_cuniculus Oryctolagus cuniculus] with PLP and BN2 as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Phosphorylase Phosphorylase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.4.1.1 2.4.1.1] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1WUT OCA].  
1WUT is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Oryctolagus_cuniculus Oryctolagus cuniculus] with <scene name='pdbligand=PLP:'>PLP</scene> and <scene name='pdbligand=BN2:'>BN2</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Phosphorylase Phosphorylase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.4.1.1 2.4.1.1] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1WUT OCA].  


==Reference==
==Reference==
Line 15: Line 15:
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Brachvogel, V.]]
[[Category: Brachvogel, V.]]
[[Category: Burger, H.J.]]
[[Category: Burger, H J.]]
[[Category: Defossa, E.]]
[[Category: Defossa, E.]]
[[Category: Herling, A.W.]]
[[Category: Herling, A W.]]
[[Category: Kadereit, D.]]
[[Category: Kadereit, D.]]
[[Category: Klabunde, T.]]
[[Category: Klabunde, T.]]
[[Category: Kosmopoulou, M.N.]]
[[Category: Kosmopoulou, M N.]]
[[Category: Oikonomakos, N.G.]]
[[Category: Oikonomakos, N G.]]
[[Category: Roedern, E.von.]]
[[Category: Roedern, E von.]]
[[Category: Sarubbi, E.]]
[[Category: Sarubbi, E.]]
[[Category: Schmoll, D.]]
[[Category: Schmoll, D.]]
[[Category: Schonafinger, K.]]
[[Category: Schonafinger, K.]]
[[Category: Wendt, K.U.]]
[[Category: Wendt, K U.]]
[[Category: BN2]]
[[Category: BN2]]
[[Category: PLP]]
[[Category: PLP]]
Line 32: Line 32:
[[Category: type 2 diabetes]]
[[Category: type 2 diabetes]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Wed Nov 21 05:41:15 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 15:48:18 2008''